Veracyte, Inc. VCYT

US Biotechnology

$25.34 ▼ -2.24% ($-0.58)

Open $25.67

Prev Close $25.92

Day Range $24.58 – $25.89

52W Range $21.91 – $60.91

Market Cap $4.02B

P/E (TTM) 18.15

Beta 2.06

EPS (TTM) $1.40

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2013-10-30
Shares Out.	80,390,000
Website	veracyte.com/ ↗
Phone	13026587581
Employees	755
Revenue	$151.8M
Gross Profit	$107.1M
Net Income	$31.5M
Free Cash Flow	$161.9M
Total Assets	$1.57B
Total Liabilities	$140.0M
Equity	$1.43B

About Veracyte, Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Veracyte, Inc. is a publicly traded company under the ticker symbol VCYT on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.